Breakdown | ||
TTM | Sep 2024 | |
---|---|---|
Income Statement | Total Revenue | |
17.55B | 17.49B | Gross Profit |
5.66B | 7.81B | EBIT |
-109.00M | 2.67B | EBITDA |
4.61B | 4.03B | Net Income Common Stockholders |
2.41B | 1.97B | |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |
3.59B | 3.59B | Total Assets |
44.25B | 44.25B | Total Debt |
7.69B | 7.69B | Net Debt |
4.10B | 4.10B | Total Liabilities |
16.74B | 16.74B | Stockholders Equity |
21.64B | 21.64B | |
Cash Flow | Free Cash Flow | |
3.27B | 2.91B | Operating Cash Flow |
3.69B | 3.33B | Investing Cash Flow |
2.95B | -5.36B | Financing Cash Flow |
-5.80B | -2.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $25.26B | 9.47 | 38.79% | 1.06% | -2.99% | 159.26% | |
74 Outperform | $64.30B | 27.12 | 9.14% | 1.80% | 10.29% | 22.72% | |
74 Outperform | $109.16B | 29.31 | 20.52% | 1.35% | 7.25% | 18.36% | |
74 Outperform | $213.34B | 33.27 | 33.90% | 0.55% | -32.60% | -28.55% | |
68 Neutral | $135.18B | 23.89 | 596.13% | 2.08% | 5.05% | 2.73% | |
66 Neutral | $31.51B | 34.67 | 27.22% | 1.84% | -11.28% | -23.69% | |
62 Neutral | $8.11B | 13.34 | 1.17% | 3.02% | 4.16% | -15.14% |
Emerson reported strong financial performance for fiscal year 2024, with a 15% increase in net sales to $17.5 billion and a rise in adjusted earnings per share by 24% to $5.49. The company highlights its strategic transformation towards becoming a leader in industrial technology by integrating Test & Measurement, realizing significant synergies, and maintaining a focus on automation solutions. Emerson’s solid results and future strategic actions aim to deliver continued growth and value for shareholders in 2025.